Savara, Inc. (SVRA)
4.22
-0.32
(-7.05%)
USD |
NASDAQ |
Oct 23, 16:00
4.28
+0.06
(+1.42%)
After-Hours: 20:00
Savara Price to Book Value : 6.034 for Oct. 23, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 6.034 |
| October 22, 2026 | 6.491 |
| October 21, 2026 | 6.677 |
| October 20, 2026 | 6.806 |
| October 19, 2026 | 6.620 |
| October 16, 2026 | 6.362 |
| October 15, 2026 | 6.777 |
| October 14, 2026 | 6.806 |
| October 13, 2026 | 6.834 |
| October 12, 2026 | 6.92 |
| October 09, 2026 | 7.034 |
| October 08, 2026 | 6.906 |
| October 07, 2026 | 6.977 |
| October 06, 2026 | 6.648 |
| October 05, 2026 | 6.834 |
| October 02, 2026 | 6.877 |
| October 01, 2026 | 7.213 |
| September 30, 2026 | 7.378 |
| September 29, 2026 | 7.263 |
| September 28, 2026 | 7.249 |
| September 25, 2026 | 7.149 |
| September 24, 2026 | 7.249 |
| September 23, 2026 | 7.149 |
| September 22, 2026 | 7.578 |
| September 21, 2026 | 7.792 |
| Date | Value |
|---|---|
| September 18, 2026 | 7.678 |
| September 17, 2026 | 7.749 |
| September 16, 2026 | 7.335 |
| September 15, 2026 | 7.520 |
| September 14, 2026 | 7.635 |
| September 11, 2026 | 7.578 |
| September 10, 2026 | 7.606 |
| September 09, 2026 | 7.742 |
| September 08, 2026 | 7.907 |
| September 04, 2026 | 7.678 |
| September 03, 2026 | 7.678 |
| September 02, 2026 | 7.806 |
| September 01, 2026 | 7.649 |
| August 31, 2026 | 7.706 |
| August 28, 2026 | 7.520 |
| August 27, 2026 | 7.849 |
| August 26, 2026 | 8.021 |
| August 25, 2026 | 8.007 |
| August 24, 2026 | 7.949 |
| August 21, 2026 | 7.992 |
| August 20, 2026 | 7.849 |
| August 19, 2026 | 7.978 |
| August 18, 2026 | 7.678 |
| August 17, 2026 | 7.678 |
| August 14, 2026 | 7.692 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Gilead Sciences, Inc. | 16.37 |
| Insmed, Inc. | 26.91 |
| United Therapeutics Corp. | 3.917 |
| Vertex Pharmaceuticals, Inc. | 6.556 |
| ACADIA Pharmaceuticals, Inc. | 2.599 |
Price to Book Value Related Metrics
| PEG Ratio | -0.5903 |
| Price | 4.22 |
| Earnings Yield | -13.66% |
| Market Cap | 866.79M |
| PEGY Ratio | -0.5903 |